$0.11

-0.00 (-2.06%)

Weekly Expected Move ±10.6%

$0 $0 $0 $0 $0

NASDAQ · Healthcare · Medical - Distribution · Tech Score Sell · Power 29 · $1.2M mcap · 3M float · 87.40% daily turnover · Short 31% of daily vol

Revenue

$13M -33.9% ▼

3Y CAGR: +2.3%

Gross Profit

$1M -42.6% ▼

3Y CAGR: -20.3%

Operating Income

-$995K -853.5% ▼

Net Income

-$1M -4098.6% ▼

EPS (Diluted)

$-0.05 -1510.0% ▼

EBITDA

-$918K -176.1% ▼

View Full Income Statement

Line Item	FY2023	FY2024	FY2025	FY2026
Revenue	$13M	$17M	$20M	$13M
YoY Growth	+0.0%	+32.9%	+21.7%	-33.9%
Cost of Revenue	$10M	$13M	$18M	$12M
Gross Profit	$3M	$4M	$2M	$1M
Gross Margin	21.8%	21.3%	11.9%	10.3%
R&D Expenses	$0	$0	$0	$0
SG&A Expenses	$2M	$2M	$2M	$2M
Operating Expenses	$2M	$2M	$2M	$2M
Operating Income	$1M	$2M	$132K	-$995K
Operating Margin	8.3%	9.6%	0.6%	-7.4%
Interest Expense	$23K	$83K	$98K	$133K
Income Before Tax	$1M	$2M	$36K	-$1M
Tax Expense	$23K	$196K	$63K	$8K
Net Income	$998K	$1M	-$27K	-$1M
Net Margin	7.9%	8.0%	-0.1%	-8.5%
EPS (Diluted)	$0.09	$0.18	$-0.00	$-0.05
EBITDA	$2M	$3M	$1M	-$918K
Shares Outstanding	11M	7M	10M	23M

Line Item	FY2024 Q2	FY2024 Q4	FY2025 Q2	FY2025 Q4	FY2026 Q2	FY2026 Q4
Revenue	$7M	$10M	$11M	$9M	$7M	$6M
Cost of Revenue	$6M	$7M	$9M	$9M	$6M	$6M
Gross Profit	$1M	$2M	$2M	$510K	$931K	$456K
Gross Margin	19.1%	23.0%	17.2%	5.5%	13.0%	7.2%
R&D Expenses	$0	$0	$0	$0	$0	$0
SG&A Expenses	$995K	$895K	$881K	$1M	$725K	$2M
Operating Expenses	$1M	$923K	$879K	$1M	$696K	$2M
Operating Income	$309K	$1M	$1M	-$895K	$234K	-$1M
Operating Margin	4.4%	13.4%	9.3%	-9.7%	3.3%	-19.5%
Interest Expense	$35K	$48K	$48K	$48K	$63K	$71K
Income Before Tax	$274K	$1M	$979K	-$943K	$172K	-$1M
Tax Expense	$25K	$171K	$150K	$87K	$18K	-$10K
Net Income	$249K	$1M	$829K	-$856K	$154K	-$1M
Net Margin	3.6%	11.2%	7.5%	-9.3%	2.2%	-20.5%
EPS (Diluted)	$0.04	$0.11	$0.08	$-0.08	$0.01	$-0.04
EBITDA	$371K	$1M	$1M	-$793K	$259K	-$1M
Shares Outstanding	7M	10M	10M	10M	11M	36M

HKPD NASDAQ